Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2003
10/07/2003US6630467 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy
10/07/2003US6630165 For sustained release; therapy
10/07/2003US6630157 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2287552C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2279692C Novel 4-amino-1-arylpyridin-2-ones having anticonvulsive activity and processes for their preparation
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2250077C Use of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders
10/07/2003CA2244402C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
10/07/2003CA2123685C Medicament for promoting growth of mammalian nerve
10/07/2003CA2107105C Heterocyclic-cyclic amine derivatives
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003080864A1 Histone deacetylase: novel molecular target of neurotoxicity
10/02/2003WO2003080841A1 Calcineurin activators
10/02/2003WO2003080836A1 Nerve regeneration genes
10/02/2003WO2003080831A1 Nuclear receptor errϝ3
10/02/2003WO2003080818A1 Method of inducing growth of nerve stem cells
10/02/2003WO2003080805A2 Kinases and phosphatases
10/02/2003WO2003080678A1 Modified saccharides having improved stability in water
10/02/2003WO2003080673A1 Costimulatory molecule and its use
10/02/2003WO2003080662A1 Protein kinase c modulators, their aminoacid and nucleotide sequences and uses thereof
10/02/2003WO2003080626A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
10/02/2003WO2003080625A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
10/02/2003WO2003080619A1 Fused bicyclic pyrimidine derivatives
10/02/2003WO2003080617A1 Pyrazolopyrimidine derivatives
10/02/2003WO2003080611A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
10/02/2003WO2003080610A1 Imidazopyridine derivatives as kinase inhibitors
10/02/2003WO2003080609A1 Pyrazolopyrimidines derivatives
10/02/2003WO2003080608A2 Quinoline and aza-indole derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives
10/02/2003WO2003080598A1 Deuterated substituted indoles and medicaments containing said compounds
10/02/2003WO2003080597A1 Method for manufacture of sertindole
10/02/2003WO2003080594A1 Substituted chroman derivatives having cytochrome p450rai inhibitory activity
10/02/2003WO2003080588A1 Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
10/02/2003WO2003080586A1 N-sulfonylurea apoptosis promoters
10/02/2003WO2003080582A2 Fredericamycin derivatives
10/02/2003WO2003080581A1 Phenanthridinones as parp inhibitors
10/02/2003WO2003080580A2 Quinoline derivatives and their use as 5-ht6 ligands
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080578A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003WO2003080573A1 Phthalimido derivatives as inhibitors of monoamine oxidase b
10/02/2003WO2003080569A2 Egfr ligands and methods of use
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080566A2 Hif hydroxylase inhibitors
10/02/2003WO2003080557A1 Substituted 4-aminocyclohexanols
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2003080125A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
10/02/2003WO2003080122A1 Method and agent for producing therapeutically active blood compositions
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080087A1 Pharmaceutical composition containing an extract from barleria prionitis linn and its process of preparation
10/02/2003WO2003080085A1 Plant extracts and the use thereof
10/02/2003WO2003080074A1 Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof
10/02/2003WO2003080071A1 Novel therapeutical use of agonist ligands specific to g2a receptor
10/02/2003WO2003080069A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003WO2003080068A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
10/02/2003WO2003080065A1 Crystalline forms of quetiapine hemifumarate
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080055A1 Pharmaceutical compositions comprising a benzofuran derivative and their use for the treatment of attention deficit/hyperactivity disorder
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080050A1 The use of 3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl]-6-chloro-1h-indole or its enantiomers for the treatment of diseases and disorders responsive to 5-ht (serotonin) re-uptake inhibition
10/02/2003WO2003080049A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003WO2003080047A1 Phosphate prodrugs of fluorooxindoles
10/02/2003WO2003080046A1 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane nmda, 5ht3, and neuronal nicotinic receptor antagoni sts
10/02/2003WO2003080031A1 Sustained release formulation of tramadol
10/02/2003WO2003080029A1 No-donating nsaids adsorbed into carrier particles
10/02/2003WO2003080022A2 Analgesics for nasal administration
10/02/2003WO2003080021A2 Formulation comprising buprenorphine
10/02/2003WO2003079998A2 Treatment of diseases involving defective gap junctional communication
10/02/2003WO2003079987A2 A non-selective cation channel in neural cells and methods for treating brain swelling
10/02/2003WO2003079986A2 Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
10/02/2003WO2003079976A2 A substance with sedative effect
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003079945A1 Method of administering buprenorphine to treat depression
10/02/2003WO2003079818A1 Alertness bar
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003053358A3 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
10/02/2003WO2003050139A3 Prion inhibiting peptides and derivatives thereof
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003011906A3 Use of peptide fragments of the calcium channel α-1 subunit, optionally comprising mutations, for screening molecules of therapeutic interest
10/02/2003WO2003002107A3 Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms)
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002087552A3 Androgen-mediated neuroprotection and uses thereof
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002055481A8 Prodrugs of excitatory amino acids
10/02/2003WO2002030870A3 Substituted c-cyclohexylmethylamine derivatives
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002005782A3 Stable salts of o-acetylsalicyclic with basic amino acids
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187268 Imidazole derivatives
10/02/2003US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders
10/02/2003US20030187058 Synergistic mixture of lipoic acid and another fatty acid; antidiabetic agents
10/02/2003US20030187052 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
10/02/2003US20030187047 Vision defects; non-insulin diabetic agents; impotency; dietetics
10/02/2003US20030187040 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
10/02/2003US20030187035 Substituted hydrazones as inhibitors of cyclooxygenase-2
1 ... 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 ... 1833